Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ICUI's Cash to Debt is ranked higher than
95% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. ICUI: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ICUI' s 10-Year Cash to Debt Range
Min: No Debt  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.94
ICUI's Equity to Asset is ranked higher than
98% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. ICUI: 0.94 )
Ranked among companies with meaningful Equity to Asset only.
ICUI' s 10-Year Equity to Asset Range
Min: 0.85  Med: 0.92 Max: 0.96
Current: 0.94
0.85
0.96
Interest Coverage No Debt
ICUI's Interest Coverage is ranked higher than
91% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. ICUI: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ICUI' s 10-Year Interest Coverage Range
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 6
Z-Score: 36.49
M-Score: -2.56
WACC vs ROIC
4.13%
21.91%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 16.04
ICUI's Operating margin (%) is ranked higher than
80% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. ICUI: 16.04 )
Ranked among companies with meaningful Operating margin (%) only.
ICUI' s 10-Year Operating margin (%) Range
Min: 7.83  Med: 20.46 Max: 34.17
Current: 16.04
7.83
34.17
Net-margin (%) 11.49
ICUI's Net-margin (%) is ranked higher than
78% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. ICUI: 11.49 )
Ranked among companies with meaningful Net-margin (%) only.
ICUI' s 10-Year Net-margin (%) Range
Min: 6.62  Med: 13.91 Max: 22.42
Current: 11.49
6.62
22.42
ROE (%) 7.29
ICUI's ROE (%) is ranked higher than
57% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. ICUI: 7.29 )
Ranked among companies with meaningful ROE (%) only.
ICUI' s 10-Year ROE (%) Range
Min: 3.2  Med: 11.73 Max: 16.19
Current: 7.29
3.2
16.19
ROA (%) 6.83
ICUI's ROA (%) is ranked higher than
71% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. ICUI: 6.83 )
Ranked among companies with meaningful ROA (%) only.
ICUI' s 10-Year ROA (%) Range
Min: 3.04  Med: 10.98 Max: 14.64
Current: 6.83
3.04
14.64
ROC (Joel Greenblatt) (%) 33.67
ICUI's ROC (Joel Greenblatt) (%) is ranked higher than
77% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. ICUI: 33.67 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ICUI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.82  Med: 32.06 Max: 74.5
Current: 33.67
8.82
74.5
Revenue Growth (3Y)(%) -2.50
ICUI's Revenue Growth (3Y)(%) is ranked lower than
75% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. ICUI: -2.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ICUI' s 10-Year Revenue Growth (3Y)(%) Range
Min: -2.5  Med: 16.60 Max: 34.6
Current: -2.5
-2.5
34.6
EBITDA Growth (3Y)(%) -14.10
ICUI's EBITDA Growth (3Y)(%) is ranked lower than
87% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. ICUI: -14.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ICUI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -19.8  Med: 18.40 Max: 35.1
Current: -14.1
-19.8
35.1
EPS Growth (3Y)(%) -18.90
ICUI's EPS Growth (3Y)(%) is ranked lower than
83% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. ICUI: -18.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ICUI' s 10-Year EPS Growth (3Y)(%) Range
Min: -32.2  Med: 16.50 Max: 66
Current: -18.9
-32.2
66
» ICUI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

ICUI Guru Trades in Q3 2014

Paul Tudor Jones 85,463 sh (+1.44%)
Chuck Royce 700 sh (unchged)
Mario Gabelli 122,200 sh (-2.71%)
Jim Simons 557,900 sh (-13.57%)
Joel Greenblatt 118,526 sh (-47.11%)
» More
Q4 2014

ICUI Guru Trades in Q4 2014

Chuck Royce 700 sh (unchged)
Jim Simons 544,741 sh (-2.36%)
Joel Greenblatt 114,420 sh (-3.46%)
Mario Gabelli 113,300 sh (-7.28%)
Paul Tudor Jones 60,600 sh (-29.09%)
» More
Q1 2015

ICUI Guru Trades in Q1 2015

Jim Simons 609,700 sh (+11.92%)
Chuck Royce Sold Out
Joel Greenblatt 112,650 sh (-1.55%)
Mario Gabelli 98,700 sh (-12.89%)
Paul Tudor Jones 3,157 sh (-94.79%)
» More
Q2 2015

ICUI Guru Trades in Q2 2015

Steven Cohen 10,500 sh (New)
Joel Greenblatt 221,078 sh (+96.25%)
Paul Tudor Jones 5,067 sh (+60.50%)
Jim Simons 688,734 sh (+12.96%)
Mario Gabelli 73,700 sh (-25.33%)
» More
» Details

Insider Trades

Latest Guru Trades with ICUI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 47.86
ICUI's P/E(ttm) is ranked lower than
77% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.00 vs. ICUI: 47.86 )
Ranked among companies with meaningful P/E(ttm) only.
ICUI' s 10-Year P/E(ttm) Range
Min: 13.77  Med: 23.36 Max: 106.63
Current: 47.86
13.77
106.63
Forward P/E 28.33
ICUI's Forward P/E is ranked lower than
76% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.74 vs. ICUI: 28.33 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 49.30
ICUI's PE(NRI) is ranked lower than
80% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.40 vs. ICUI: 49.30 )
Ranked among companies with meaningful PE(NRI) only.
ICUI' s 10-Year PE(NRI) Range
Min: 13.78  Med: 23.32 Max: 106
Current: 49.3
13.78
106
P/B 3.22
ICUI's P/B is ranked lower than
55% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. ICUI: 3.22 )
Ranked among companies with meaningful P/B only.
ICUI' s 10-Year P/B Range
Min: 1.4  Med: 2.15 Max: 3.57
Current: 3.22
1.4
3.57
P/S 5.50
ICUI's P/S is ranked lower than
74% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. ICUI: 5.50 )
Ranked among companies with meaningful P/S only.
ICUI' s 10-Year P/S Range
Min: 1.73  Med: 2.92 Max: 6.58
Current: 5.5
1.73
6.58
PFCF 37.31
ICUI's PFCF is ranked lower than
66% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.56 vs. ICUI: 37.31 )
Ranked among companies with meaningful PFCF only.
ICUI' s 10-Year PFCF Range
Min: 11.24  Med: 24.40 Max: 98.42
Current: 37.31
11.24
98.42
POCF 30.92
ICUI's POCF is ranked lower than
74% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.43 vs. ICUI: 30.92 )
Ranked among companies with meaningful POCF only.
ICUI' s 10-Year POCF Range
Min: 9.22  Med: 14.90 Max: 34.12
Current: 30.92
9.22
34.12
EV-to-EBIT 26.77
ICUI's EV-to-EBIT is ranked lower than
68% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.58 vs. ICUI: 26.77 )
Ranked among companies with meaningful EV-to-EBIT only.
ICUI' s 10-Year EV-to-EBIT Range
Min: 7  Med: 12.90 Max: 71.3
Current: 26.77
7
71.3
PEG 123.25
ICUI's PEG is ranked lower than
98% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. ICUI: 123.25 )
Ranked among companies with meaningful PEG only.
ICUI' s 10-Year PEG Range
Min: 0.6  Med: 1.69 Max: 752.14
Current: 123.25
0.6
752.14
Shiller P/E 42.86
ICUI's Shiller P/E is ranked lower than
75% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.14 vs. ICUI: 42.86 )
Ranked among companies with meaningful Shiller P/E only.
ICUI' s 10-Year Shiller P/E Range
Min: 16.32  Med: 25.79 Max: 47.21
Current: 42.86
16.32
47.21
Current Ratio 16.43
ICUI's Current Ratio is ranked higher than
98% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. ICUI: 16.43 )
Ranked among companies with meaningful Current Ratio only.
ICUI' s 10-Year Current Ratio Range
Min: 5.86  Med: 10.19 Max: 23.06
Current: 16.43
5.86
23.06
Quick Ratio 15.09
ICUI's Quick Ratio is ranked higher than
99% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. ICUI: 15.09 )
Ranked among companies with meaningful Quick Ratio only.
ICUI' s 10-Year Quick Ratio Range
Min: 4.57  Med: 9.41 Max: 22
Current: 15.09
4.57
22
Days Inventory 86.99
ICUI's Days Inventory is ranked higher than
75% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. ICUI: 86.99 )
Ranked among companies with meaningful Days Inventory only.
ICUI' s 10-Year Days Inventory Range
Min: 19.11  Med: 59.45 Max: 101.19
Current: 86.99
19.11
101.19
Days Sales Outstanding 49.13
ICUI's Days Sales Outstanding is ranked higher than
76% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.01 vs. ICUI: 49.13 )
Ranked among companies with meaningful Days Sales Outstanding only.
ICUI' s 10-Year Days Sales Outstanding Range
Min: 40.82  Med: 54.96 Max: 84.81
Current: 49.13
40.82
84.81

Valuation & Return

vs
industry
vs
history
Price/Net Cash 5.18
ICUI's Price/Net Cash is ranked higher than
76% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.72 vs. ICUI: 5.18 )
Ranked among companies with meaningful Price/Net Cash only.
ICUI' s 10-Year Price/Net Cash Range
Min: 2.24  Med: 5.69 Max: 575
Current: 5.18
2.24
575
Price/Net Current Asset Value 3.96
ICUI's Price/Net Current Asset Value is ranked higher than
71% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.89 vs. ICUI: 3.96 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ICUI' s 10-Year Price/Net Current Asset Value Range
Min: 1.72  Med: 3.33 Max: 5.21
Current: 3.96
1.72
5.21
Price/Tangible Book 3.28
ICUI's Price/Tangible Book is ranked higher than
61% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. ICUI: 3.28 )
Ranked among companies with meaningful Price/Tangible Book only.
ICUI' s 10-Year Price/Tangible Book Range
Min: 1.31  Med: 2.41 Max: 4.06
Current: 3.28
1.31
4.06
Price/Projected FCF 2.27
ICUI's Price/Projected FCF is ranked lower than
67% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. ICUI: 2.27 )
Ranked among companies with meaningful Price/Projected FCF only.
ICUI' s 10-Year Price/Projected FCF Range
Min: 0.79  Med: 1.51 Max: 2.63
Current: 2.27
0.79
2.63
Price/Median PS Value 1.88
ICUI's Price/Median PS Value is ranked lower than
86% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. ICUI: 1.88 )
Ranked among companies with meaningful Price/Median PS Value only.
ICUI' s 10-Year Price/Median PS Value Range
Min: 0.6  Med: 1.11 Max: 2.45
Current: 1.88
0.6
2.45
Price/Graham Number 2.61
ICUI's Price/Graham Number is ranked lower than
54% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. ICUI: 2.61 )
Ranked among companies with meaningful Price/Graham Number only.
ICUI' s 10-Year Price/Graham Number Range
Min: 0.88  Med: 1.49 Max: 3.53
Current: 2.61
0.88
3.53
Earnings Yield (Greenblatt) (%) 3.73
ICUI's Earnings Yield (Greenblatt) (%) is ranked higher than
55% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. ICUI: 3.73 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ICUI' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.4  Med: 7.70 Max: 14.4
Current: 3.73
1.4
14.4
Forward Rate of Return (Yacktman) (%) -3.18
ICUI's Forward Rate of Return (Yacktman) (%) is ranked lower than
83% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.13 vs. ICUI: -3.18 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ICUI' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -3.3  Med: 14.30 Max: 28.2
Current: -3.18
-3.3
28.2

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 329 340
EPS($) 3.39 3.88
EPS without NRI($) 3.39 3.88

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:IC7.Germany,
ICU Medical Inc is a Delaware Corporation founded in 1984 and its initial public offering was in 1992. The Company is engaged in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications. Its products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. The Company's complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needle free infusion connectors, catheters and cardiac monitoring systems. Its products are categorized into three main product lines: Infusion Therapy, Critical Care and Oncology. I.V. therapy lines, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient's vein. The tube typically has several injection ports or Y-sites (conventionally, entry tubes covered by rubber caps) to which a secondary I.V. line can be connected to permit constant intravenous administration of medications, fluids and nutrients, and to allow instantaneous intravenous administration of emergency medication. Critical care products are used to monitor vital signs as well as specific physiological functions of key organ systems and Oncology: Oncology products are used to prepare and deliver hazardous medications such as those used in chemotherapy which, if released, can have harmful effects to the healthcare worker and environment. Manufacturing of its products involves injection molding of plastic and silicone parts, manual and automated assembly of the molded plastic parts, needles and other components, quality control inspection, packaging and sterilization. The Company currently sells all of its products to I.V. product manufacturers, independent distributors and direct sales to the end user. It competes with other manufacturers of closed system transfer devices for the safe handling of oncology drugs, notably Becton Dickinson, CareFusion and B Braun. The Company's products are subject to clearance by the United States Food and Drug Administration ("FDA") under a number of statutes including the Food Drug and Cosmetics Act ("FDC Act").
» More Articles for ICUI

Headlines

Articles On GuruFocus.com
EW: Potential for Capital Appreciation Oct 03 2014 
Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH Mar 10 2014 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 2,388 Shares Nov 29 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 18,831 Shares Nov 24 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,406 Shares Nov 15 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 3,691 Shares Nov 09 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,500 Shares Nov 08 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 5,684 Shares Nov 05 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,000 Shares Nov 03 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 9,496 Shares Nov 02 2010 

More From Other Websites
Increased Earnings Estimates Seen for ICU Medical (ICUI): Can It Move Higher? Sep 01 2015
How ICU Medical (ICUI) Stock Stands Out in a Strong Industry Aug 24 2015
ICU MEDICAL INC/DE Financials Aug 20 2015
New Strong Buy Stocks for August 17th Aug 17 2015
ICU Medical, Inc.: Leads amongst peers with strong fundamentals Aug 12 2015
Strength Seen in ICU Medical (ICUI): Stock Soars 18.2% Aug 12 2015
Mid-Day Market Update: Dow Tumbles Over 200 Points; Crude Oil Slides 4% Aug 11 2015
Mid-Morning Market Update: Markets Tumble; Google Creates 'Alphabet,' A New Umbrella Company Aug 11 2015
Edited Transcript of ICUI earnings conference call or presentation 10-Aug-15 8:30pm GMT Aug 11 2015
ICU Medical beats 2Q profit forecasts Aug 10 2015
ICU Medical beats 2Q profit forecasts Aug 10 2015
ICU Medical Raises 2015 Outlook Aug 10 2015
ICU Medical Inc Earnings Call scheduled for 4:30 pm ET today Aug 10 2015
ICU MEDICAL INC/DE Files SEC form 8-K, Financial Statements and Exhibits Aug 10 2015
ICU Medical, Inc. Announces Second Quarter 2015 Results Aug 10 2015
Q2 2015 ICU Medical Inc Earnings Release - After Market Close Aug 10 2015
ICU Medical, Inc. Announces Time of Second Quarter 2015 Earnings Call Jul 20 2015
ICU MEDICAL INC/DE Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 16 2015
ICU Medical (ICUI) Shows Strength: Stock Gains 8.9% - Tale of the Tape May 07 2015
ICU MEDICAL INC/DE Files SEC form 10-Q, Quarterly Report May 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK